Држава: Малта
Језик: Енглески
Извор: Medicines Authority
Besins Healthcare SA Avenue Louise, 287-Boite 6, 1050 Brussels, Belgium
G03DA04
PROGESTERONE 400 mg
VAGINAL SOFT CAPSULE
PROGESTERONE 400 mg
POM
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
Authorised
2023-10-10
Page 1 of 4 PACKAGE LEAFLET: INFORMATION FOR THE USER UTROGESTAN 400 MG SOFT VAGINAL CAPSULES progesterone WHAT IS IN THIS LEAFLET: 1. What Utrogestan Vaginal 400 mg Capsule, soft is and what it is used for 2. What you need to know before you Utrogestan Vaginal 400 mg Capsule, soft 3. How to use Utrogestan Vaginal 400 mg Capsule, soft 4. Possible side effects 5. How to store Utrogestan Vaginal 400 mg Capsule, soft 6. Contents of the pack and other information 1. WHAT UTROGESTAN VAGINAL 400 MG CAPSULE, SOFT IS AND WHAT IT IS USED FOR The name of your medicine is Utrogestan Vaginal 400 mg Capsule, soft (called Utrogestan Vaginal 400 mg Capsule, soft in this package leaflet). Utrogestan Vaginal 400 mg Capsule, soft contains a hormone called progesterone. WHAT UTROGESTAN VAGINAL 400 MG CAPSULE, SOFT IS USED FOR Utrogestan Vaginal 400 mg Capsule, soft can be used to help pregnancy. TO HELP PREGNANCY Utrogestan Vaginal 400 mg Capsule, soft can be used to help women reduce the risk of miscarriage in women with bleeding in the current pregnancy and a history of recurrent miscarriages. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE UTROGESTAN VAGINAL 400 MG CAPSULE, SOFT DO NOT USE UTROGESTAN VAGINAL 400 MG CAPSULE, SOFT • if you are allergic (hypersensitive) to soya or peanuts • if you are allergic to progesterone or any of the other ingredients of this medicine (listed in section 6) • if you have liver problems • if you have yellowing of the skin or eyes (jaundice) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Use this medicine exactly as described in this package leaflet or as your doctor, pharmacist or nurse have instructed. - Keep this leaflet. You may need to read it again. - If you have questions, consult your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you notice any side effects, talk to your docto Прочитајте комплетан документ
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Utrogestan 400 mg soft vaginal capsules 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains 400 mg progesterone. Excipient(s) with known effect: soyabean lecithin. For the full list of excipients, see Section 6.1. 3. PHARMACEUTICAL FORM Soft vaginal capsules. Oblong yellowish, soft capsule (approximately 2.5 cm x 0.9 cm) containing a whitish oily suspension. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Utrogestan Vaginal 400 mg Capsule, soft is indicated for the prevention of miscarriage in women presenting with bleeding in the first trimester of pregnancy and have a history of recurrent miscarriages (see sections 4.2 and 5.1). 4.2 POSOLOGY AND ADMINISTRATION Treatment should always be individualised to the patient. The decision to treat women who have experienced recurrent miscarriages should follow further investigation and is at the discretion of the clinician. Posology VAGINAL USE ONLY. The recommended dose is 400 mg twice a day (morning and night). Treatment should be initiated during the first trimester of pregnancy, at first sign of vaginal bleeding (see Section 4.4 Special Warnings and Precautions for Use) and should continue to the 16th week of gestation. _Paediatric population _ There is no relevant use of Utrogestan Vaginal 400 mg Capsule, soft in the paediatric population. _Elderly patients _ There is no relevant use of Utrogestan Vaginal 400 mg Capsule, soft in the elderly. Method of administration Vaginal Each Utrogestan Vaginal 400 mg Capsule, soft capsule must be inserted deep into the vagina. Page 2 of 6 4.3 CONTRAINDICATIONS • Hypersensitivity to the active substance or to any of the excipients listed in Section 6.1 • Jaundice • Severe hepatic dysfunction • Undiagnosed vaginal bleeding • Mammary or genital tract carcinoma • Thrombophlebitis • Thromboembolic disorders • Cerebral haemorrhage • Porphyria • Allergy to nuts or soya (see Section 4.4) 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Прочитајте комплетан документ